Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin + Chemo in Pancreatic Endocrine Tumors
NCT00609765Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- Aug 2007
- Primary completion
- Mar 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Pancreatic neuroendocrine tumor (PNET), sponsored by Moffitt Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
bevacizumab
03
Conditions
Pancreatic neuroendocrine tumor (PNET)
Beyond the preview
Go deeper on NCT00609765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609765.